Unika Pharmaceuticals Private Limited

Zoledronic Acid Injection is a prescription medication used to treat and prevent a range of serious bone conditions. It belongs to the class of bisphosphonates and is primarily indicated for the treatment of osteoporosis, Paget’s disease of bone, and bone complications associated with cancer such as bone metastases and hypercalcemia of malignancy. Designed for intravenous use, this powerful injection helps in increasing bone density and reducing the risk of fractures, especially in postmenopausal women and cancer patients.

This injection works by slowing down bone resorption – the process by which bone is broken down – allowing bones to remain stronger and healthier for a longer duration. Zoledronic Acid Injection is often administered once a year or at medically recommended intervals, making it a convenient and long-lasting treatment option.

Manufactured under strict quality standards, this injection offers effective, targeted therapy with long-lasting results. It is typically used under medical supervision in hospitals or clinics, ensuring safe and controlled administration. It helps improve the quality of life in patients suffering from conditions that weaken the bones and cause calcium imbalances. 

Alendronic Acid (70mg), branded as ALENDROS 70, is a medication primarily used to treat and prevent osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It belongs to a class of drugs called bisphosphonates.

Alendronic Acid 35 mg is a prescription medication used primarily for the treatment and prevention of osteoporosis in postmenopausal women and men. It belongs to a class of drugs called bisphosphonates, which help strengthen bones by slowing down the rate at which bone is broken down in the body. This improves bone density and reduces the risk of fractures, particularly in the hip, spine, and wrist.